TY - JOUR

T1 - Personalized medicine in context

T2 - social science perspectives

AU - Tutton, Richard

AU - Jamie, Kimberly

PY - 2013

Y1 - 2013

N2 - In the 1990s, the scientific and popular press heralded the emergence of a new paradigm in drug discovery and development called pharmacogenomics (pgmx). As well as capturing the interest of scientists, policymakers and journalists, the field of personalized medicine has also been of immense interest to social scientists who research new innovations in health and biomedicine. This article reviews existing social science research on pgmx. It considers work on mapping industry involvement in pgmx; the dynamics of clinical adoption and the challenges of pgmx testing becoming a standard healthcare service; and patient and public perspectives on pgmx. In conclusion, the article reflects on the future research agenda.

AB - In the 1990s, the scientific and popular press heralded the emergence of a new paradigm in drug discovery and development called pharmacogenomics (pgmx). As well as capturing the interest of scientists, policymakers and journalists, the field of personalized medicine has also been of immense interest to social scientists who research new innovations in health and biomedicine. This article reviews existing social science research on pgmx. It considers work on mapping industry involvement in pgmx; the dynamics of clinical adoption and the challenges of pgmx testing becoming a standard healthcare service; and patient and public perspectives on pgmx. In conclusion, the article reflects on the future research agenda.

U2 - 10.1016/j.ddstr.2013.05.003

DO - 10.1016/j.ddstr.2013.05.003

M3 - Journal article

VL - 10

SP - e183-e187

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 4

ER -